Patents by Inventor Wendel Doubleday

Wendel Doubleday has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of pegylated drug-linkers and intermediates thereof
    Patent number: 11844839
    Abstract: The present invention provides improved processes for the preparation of auristatin drug-linkers with a PEG unit, as well as intermediates thereof.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: December 19, 2023
    Assignee: Seagen Inc.
    Inventors: Yunyu Mao, Philip Moquist, Anusuya Choudhury, Wendel Doubleday
  • Process for the preparation of glucuronide drug-linkers and intermediates thereof
    Patent number: 11730822
    Abstract: The present invention provides improved processes for the preparation of drug-linkers with a ?-glucuronide cleavable unit, as well as intermediates thereof.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: August 22, 2023
    Assignee: Seagen Inc.
    Inventors: Yunyu Mao, Philip Moquist, Anusuya Choudhury, Wendel Doubleday
  • ALTERNATIVE PROCESSES FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF
    Publication number: 20230002440
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 5, 2023
    Applicant: Seattle Genetics, Inc.
    Inventors: Kun-Liang WU, Qingwu JIN, Wendel DOUBLEDAY
  • PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF
    Publication number: 20220323601
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 13, 2022
    Inventors: Kun-Liang WU, Qingwu JIN, Wendel DOUBLEDAY
  • Process for the preparation of tubulysins and intermediates thereof
    Patent number: 11389543
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: July 19, 2022
    Assignee: Seagen Inc.
    Inventors: Kun-Liang Wu, Qingwu Jin, Wendel Doubleday
  • PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF
    Publication number: 20200297864
    Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
    Type: Application
    Filed: September 7, 2018
    Publication date: September 24, 2020
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Kun-Liang Wu, Qingwu Jin, Wendel Doubleday
  • PROCESS FOR THE PREPARATION OF GLUCURONIDE DRUG-LINKERS AND INTERMEDIATES THEREOF
    Publication number: 20200222553
    Abstract: The present invention provides improved processes for the preparation of drug-linkers with a ?-glucuronide cleavable unit, as well as intermediates thereof.
    Type: Application
    Filed: March 23, 2018
    Publication date: July 16, 2020
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Yunyu Mao, Philip Moquist, Anusuya Choudhury, Wendel Doubleday
  • PROCESS FOR THE PREPARATION OF PEGYLATED DRUG-LINKERS AND INTERMEDIATES THEREOF
    Publication number: 20190388546
    Abstract: The present invention provides improved processes for the preparation of auristatin drug-linkers with a PEG unit, as well as intermediates thereof.
    Type: Application
    Filed: March 24, 2017
    Publication date: December 26, 2019
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Yunyu Mao, Philip Moquist, Anusuya Choudhury, Wendel Doubleday